PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 114 filers reported holding PROVENTION BIO INC in Q3 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $578,400 | +150.3% | 24,000 | +9.8% | 0.01% | +150.0% |
Q4 2022 | $231,060 | +244.9% | 21,860 | +47.8% | 0.00% | +100.0% |
Q3 2022 | $67,000 | +15.5% | 14,792 | +1.3% | 0.00% | 0.0% |
Q2 2022 | $58,000 | -38.3% | 14,598 | +13.6% | 0.00% | 0.0% |
Q1 2022 | $94,000 | +30.6% | 12,848 | +0.4% | 0.00% | 0.0% |
Q4 2021 | $72,000 | -13.3% | 12,793 | -1.2% | 0.00% | 0.0% |
Q3 2021 | $83,000 | -26.5% | 12,947 | -3.1% | 0.00% | 0.0% |
Q2 2021 | $113,000 | -21.5% | 13,366 | -2.4% | 0.00% | 0.0% |
Q1 2021 | $144,000 | -25.8% | 13,697 | +19.9% | 0.00% | -50.0% |
Q4 2020 | $194,000 | +30.2% | 11,425 | -1.8% | 0.00% | +100.0% |
Q3 2020 | $149,000 | – | 11,631 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DG Capital Management, LLC | 417,092 | $5,351,000 | 3.22% |
Johnson & Johnson Innovation - JJDC, Inc. | 574,973 | $7,377,000 | 1.48% |
Soleus Capital Management, L.P. | 139,418 | $1,789,000 | 0.95% |
683 Capital Management, LLC | 859,314 | $11,025,000 | 0.81% |
Perceptive Advisors | 4,265,711 | $54,729,000 | 0.80% |
GILDER GAGNON HOWE & CO LLC | 2,151,402 | $27,602,000 | 0.17% |
Virtus ETF Advisers LLC | 21,485 | $276,000 | 0.14% |
RICE HALL JAMES & ASSOCIATES, LLC | 230,873 | $2,962,000 | 0.12% |
Windsor Creek Advisors, LLC | 28,492 | $366,000 | 0.10% |
Newbridge Financial Services Group, Inc. | 6,500 | $83,000 | 0.08% |